Approval · Notice of Compliance 36236 · 2025
TALVEY: Notice of Compliance 36236
Issued October 23, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36236
- Date
- October 23, 2025
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TALVEY | Not yet assigned | — |
Medicinal ingredients
- TALQUETAMAB 2 MG per ML
- TALQUETAMAB 40 MG per ML